Literature DB >> 25342547

Evaluating sepsis during continuous dialysis: are biomarkers still valid?

Patrick M Honoré1, Rita Jacobs, Elisabeth De Waele, Viola Van Gorp, Herbert D Spapen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342547     DOI: 10.1159/000363497

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


× No keyword cloud information.
  5 in total

1.  BPI fold-containing family a member 2 as a biomarker of acute kidney injury-close but no (clinical) cigar?

Authors:  Patrick M Honore; David De Bels; Herbert D Spapen
Journal:  Ann Transl Med       Date:  2018-05

2.  Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?

Authors:  Patrick M Honore; David De Bels; Rachid Attou; Sebastien Redant; Andrea Gallerani; Kianoush Kashani
Journal:  Crit Care       Date:  2019-06-13       Impact factor: 9.097

3.  Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?

Authors:  Patrick M Honore; David De Bels; Rachid Attou; Sebastien Redant; Andrea Gallerani; Kianoush Kashani
Journal:  Crit Care       Date:  2019-05-22       Impact factor: 9.097

4.  Procalcitonin to allow early detection of sepsis and multiple organ failure in severe multiple trauma: beware of some confounders.

Authors:  Patrick M Honore; Christina David; Rachid Attou; Sebastien Redant; Andrea Gallerani; David De Bels
Journal:  Crit Care       Date:  2020-01-07       Impact factor: 9.097

5.  High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!

Authors:  Patrick M Honore; Sebastien Redant; Thierry Preseau; Keitiane Kaefer; Leonel Barreto Gutierrez; Rachid Attou; Andrea Gallerani; David De Bels
Journal:  Ann Intensive Care       Date:  2021-03-15       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.